- Coordinates
 - PDB Format
 - Method
 - ELECTRON MICROSCOPY 4.40 Å
 - Oligo State
 - homo-trimer
 - Ligands
 - 17 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - 3 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
 - 9 x NAG- NAG- MAN: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
 NAG-NAG-MAN.6: 4 residues within 4Å:- Chain A: N.1098, T.1100, H.1101, F.1103
 
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.7: 1 residues within 4Å:- Chain A: N.1134
 
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.8: 7 residues within 4Å:- Chain A: T.19, N.20, T.73, N.74, G.75, T.76, K.77
 
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.20
 
NAG-NAG-MAN.16: 4 residues within 4Å:- Chain B: N.1098, T.1100, H.1101, F.1103
 
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.17: 1 residues within 4Å:- Chain B: N.1134
 
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.18: 3 residues within 4Å:- Chain B: N.20, N.74, K.77
 
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:K.77
 - Hydrogen bonds: B:N.20, B:N.20
 
NAG-NAG-MAN.27: 4 residues within 4Å:- Chain C: N.1098, T.1100, H.1101, F.1103
 
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.28: 1 residues within 4Å:- Chain C: N.1134
 
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.29: 3 residues within 4Å:- Chain C: N.20, N.74, K.77
 
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.20
 
- 28 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 NAG.30: 2 residues within 4Å:- Chain A: Y.28, N.61
 
Ligand excluded by PLIPNAG.31: 5 residues within 4Å:- Chain A: N.122, T.124, N.125, V.127, E.154
 
Ligand excluded by PLIPNAG.32: 4 residues within 4Å:- Chain A: K.147, N.148, N.149, M.153
 
Ligand excluded by PLIPNAG.33: 3 residues within 4Å:- Chain A: E.132, N.164, N.165
 
Ligand excluded by PLIPNAG.34: 2 residues within 4Å:- Chain A: N.234, T.236
 
Ligand excluded by PLIPNAG.35: 1 residues within 4Å:- Chain A: N.282
 
Ligand excluded by PLIPNAG.36: 3 residues within 4Å:- Chain A: N.343, V.367, F.374
 
Ligand excluded by PLIPNAG.37: 1 residues within 4Å:- Chain A: N.603
 
Ligand excluded by PLIPNAG.38: 1 residues within 4Å:- Chain A: N.657
 
Ligand excluded by PLIPNAG.39: 3 residues within 4Å:- Chain A: N.709, I.1130, G.1131
 
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain A: Y.1155, N.1158
 
Ligand excluded by PLIPNAG.41: 2 residues within 4Å:- Chain B: Y.28, N.61
 
Ligand excluded by PLIPNAG.42: 4 residues within 4Å:- Chain B: K.147, N.148, N.149, M.153
 
Ligand excluded by PLIPNAG.43: 1 residues within 4Å:- Chain B: N.234
 
Ligand excluded by PLIPNAG.44: 1 residues within 4Å:- Chain B: N.331
 
Ligand excluded by PLIPNAG.45: 3 residues within 4Å:- Chain B: F.338, G.339, N.343
 
Ligand excluded by PLIPNAG.46: 1 residues within 4Å:- Chain B: N.603
 
Ligand excluded by PLIPNAG.47: 1 residues within 4Å:- Chain B: N.657
 
Ligand excluded by PLIPNAG.48: 3 residues within 4Å:- Chain B: N.709, G.1131
 - Chain C: D.796
 
Ligand excluded by PLIPNAG.49: 1 residues within 4Å:- Chain B: N.1158
 
Ligand excluded by PLIPNAG.50: 1 residues within 4Å:- Chain C: N.61
 
Ligand excluded by PLIPNAG.51: 3 residues within 4Å:- Chain C: K.147, N.149, M.153
 
Ligand excluded by PLIPNAG.52: 3 residues within 4Å:- Chain C: N.331, P.579, Q.580
 
Ligand excluded by PLIPNAG.53: 3 residues within 4Å:- Chain C: G.339, N.343, V.367
 
Ligand excluded by PLIPNAG.54: 1 residues within 4Å:- Chain C: N.603
 
Ligand excluded by PLIPNAG.55: 1 residues within 4Å:- Chain C: N.657
 
Ligand excluded by PLIPNAG.56: 2 residues within 4Å:- Chain C: N.709, N.710
 
Ligand excluded by PLIPNAG.57: 1 residues within 4Å:- Chain C: N.1158
 
Ligand excluded by PLIP- Links
 - RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
 - Citation
 - Zhang, J. et al., Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant. Science (2021)
          


 - Release Date
 - 2021-11-10
 - Peptides
 - Spike glycoprotein: ABC
 - SMTL:PDB
 - SMTL Chain Id:
PDB Chain Id:A
AB
BC
C 
- Coordinates
 - PDB Format
 - Method
 - ELECTRON MICROSCOPY 4.40 Å
 - Oligo State
 - homo-trimer
 - Ligands
 - 17 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - 3 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
 - 9 x NAG- NAG- MAN: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
 - 28 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - Links
 - RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
 - Citation
 - Zhang, J. et al., Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant. Science (2021)
          


 - Release Date
 - 2021-11-10
 - Peptides
 - Spike glycoprotein: ABC
 - SMTL:PDB
 - SMTL Chain Id:
PDB Chain Id:A
AB
BC
C